Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Cameco Corp.

Start price
Target price
Perf. (%)
€36.50
19.08.24
-
19.08.25
17.77%
27.09.24

Could be very worthwhile Investment >20% year
Very capable Management
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
Denison Mines Corp.

Start price
Target price
Perf. (%)
€1.44
19.08.24
-
19.08.25
15.82%
27.09.24

EBIT growth > 30% per year expected
Rising EBIT margin expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
buy
Uranium Energy Corp

Start price
Target price
Perf. (%)
€4.42
19.08.24
-
19.08.25
29.12%
27.09.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
Energy Fuels Inc.

Start price
Target price
Perf. (%)
€4.22
19.08.24
-
19.08.25
17.83%
27.09.24

Revenue growth > 30% per year expected
Rising EBIT margin expected
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
buy
AnaptysBio Inc

Start price
Target price
Perf. (%)
€32.40
19.08.24
€43.00
31.05.26
-12.35%
27.09.24

Could be very worthwhile Investment >20% year
buy
Applovin Corp.

Start price
Target price
Perf. (%)
€78.71
19.08.24
€90.00
31.05.26
-3.23%
08.09.24

Could be very worthwhile Investment >20% year
buy
Insmed Inc.

Start price
Target price
Perf. (%)
€69.00
19.08.24
€90.00
30.06.26
-5.80%
27.09.24

Could be very worthwhile Investment >20% year
buy
Bavarian Nordic A/S

Start price
Target price
Perf. (%)
€41.01
19.08.24
€50.00
31.08.26
-23.41%
08.09.24

Could be very worthwhile Investment >20% year
buy
Applied DNA Sciences Inc.

Start price
Target price
Perf. (%)
€0.23
19.08.24
€1.00
31.10.26
-
08.09.24

Could be very worthwhile Investment >20% year
buy
Caredx Inc

Start price
Target price
Perf. (%)
€30.31
19.08.24
€40.00
31.10.26
-18.15%
08.09.24

Could be very worthwhile Investment >20% year
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.50
18.08.24
-
18.08.25
-12.06%
30.08.24

Could be very worthwhile Investment >20% year
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€2.91
18.08.24
-
18.08.25
7.14%
30.08.24

Could be worthwhile Investment >10% per year
buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.43
18.08.24
€13.00
18.08.25
-3.16%
31.08.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth > 30% per year expected
Golden Minerals Co.

Start price
Target price
Perf. (%)
€0.004
18.08.24
-
18.08.25
-
08.06.23

PNM Resources Inc.

Start price
Target price
Perf. (%)
€36.60
18.08.24
-
18.08.25
4.92%
27.09.24

Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.21
18.08.24
-
18.08.25
-
15.07.23

Englobal

Start price
Target price
Perf. (%)
€0.22
18.08.24
-
18.08.25
-
30.11.23

Glycomimetics Inc.

Start price
Target price
Perf. (%)
€0.16
18.08.24
-
18.08.25
-6.63%
26.09.24

Infinera Corp.

Start price
Target price
Perf. (%)
€5.50
18.08.24
-
18.08.25
11.82%
27.09.24

buy
Overseas Shipholding Group Inc

Start price
Target price
Perf. (%)
€7.75
18.08.24
-
18.08.25
-
10.07.24

buy
Sanofi S.A. ADR

Start price
Target price
Perf. (%)
€48.80
18.08.24
-
18.08.25
4.51%
26.09.24

buy
BYD Co. Ltd

Start price
Target price
Perf. (%)
€25.89
18.08.24
-
18.09.24
8.96%
19.09.24

Could be worthwhile Investment >10% per year
buy
Broadcom Ltd.

Start price
Target price
Perf. (%)
€150.18
18.08.24
€165.50
18.08.25
-1.62%
31.08.24

buy
Faurecia S.A.

Start price
Target price
Perf. (%)
€9.39
18.08.24
€15.00
18.08.25
3.62%
27.09.24

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Good rating
Deutsche Bank AG

Start price
Target price
Perf. (%)
€14.05
18.08.24
€11.00
18.08.25
5.14%
31.08.24

Probably not worthwhile Investment
Unknown brand
Outdated or very high risk business model
Below average Marketposition